Nonalcoholic steatohepatitis (NASH), as a more aggressive type of nonalcoholic fatty liver disease (NAFLD), has affected millions of people in the US, becoming one of the most common chronic liver diseases in the western world. Some NASH patients could develop into cirrhosis or cancer. However, no medications for the treatment of NASH have been approved … Continue reading Nonalcoholic Steatohepatitis Diagnosis and Drug Discovery Showing Promise →